Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Aptevo Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-2.090
Estimación de ingresos trimestrales
–
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Aptevo Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
APVO | Aptevo Therapeutics | -$355.20 | -$2.09 | — | — | $0.00 | — | — | — | 11/06/2025 | |
APVO | Aptevo Therapeutics | -$1.24K | -$83.20 | -$8.40 | 89.90% | $0.00 | — | $0.00 | — | 08/11/2025 | |
APVO | Aptevo Therapeutics | -$7.36K | -$83.20 | -$87.80 | -5.53% | $0.00 | — | $0.00 | — | 05/14/2025 | |
APVO | Aptevo Therapeutics | -$1.30K | -$84.20 | -$13.20 | 84.32% | $0.00 | — | $0.00 | — | 02/15/2025 | |
APVO | Aptevo Therapeutics | -$16.28K | -$2.48K | -$355.20 | 85.67% | $0.00 | — | $0.00 | — | 11/07/2024 | |
APVO | Aptevo Therapeutics | -$39.92K | -$2.90K | -$1.24K | 57.40% | $0.00 | — | $0.00 | — | 08/08/2024 | |
APVO | Aptevo Therapeutics | $8.47K | -$9.50K | -$7.36K | 22.51% | $0.00 | — | $0.00 | — | 05/08/2024 | |
APVO | Aptevo Therapeutics | -$46.89K | -$13.35K | -$1.30K | 90.24% | $0.00 | — | $0.00 | — | 03/05/2024 | |
APVO | Aptevo Therapeutics | -$48.84K | -$24.42K | -$16.28K | 33.33% | $0.00 | — | $0.00 | — | 11/14/2023 | |
APVO | Aptevo Therapeutics | -$59.26K | -$36.47K | -$40.05K | -9.82% | $0.00 | — | $0.00 | — | 08/10/2023 | |
APVO | Aptevo Therapeutics | -$50.47K | -$38.42K | -$31.91K | 16.95% | $3.11M | — | $0.00 | — | 05/11/2023 | |
APVO | Aptevo Therapeutics | -$43.30K | -$49.82K | -$46.89K | 5.88% | $3.67M | — | $0.00 | — | 03/30/2023 | |
APVO | Aptevo Therapeutics | -$46.56K | -$53.40K | -$48.84K | 8.54% | $3.10M | — | $0.00 | — | 11/10/2022 | |
APVO | Aptevo Therapeutics | -$57.96K | -$43.30K | -$59.26K | -36.84% | $3.11M | $3.42M | $0.00 | -100.00% | 08/11/2022 | |
APVO | Aptevo Therapeutics | -$53.40K | -$37.44K | -$50.47K | -34.78% | $2.42M | $3.75M | $3.11M | -16.96% | 05/12/2022 | |
APVO | Aptevo Therapeutics | -$57.63K | -$42.00K | -$43.30K | -3.10% | $2.37M | $3.40M | $3.67M | 7.79% | 03/24/2022 | |
APVO | Aptevo Therapeutics | -$70.00K | -$47.86K | -$46.56K | 2.72% | $1.46M | $3.65M | $3.10M | -15.18% | 11/12/2021 | |
APVO | Aptevo Therapeutics | -$68.38K | -$59.91K | -$57.96K | 3.26% | $473.00K | $900.00K | $3.11M | 245.56% | 08/12/2021 | |
APVO | Aptevo Therapeutics | -$78.47K | $55.03K | -$56.65K | -202.96% | $0.00 | $2.42M | $2.42M | 0.04% | 05/11/2021 | |
APVO | Aptevo Therapeutics | -$86.61K | -$42.98K | -$57.63K | -34.09% | $9.03M | $2.16M | $2.37M | 9.86% | 03/31/2021 | |
APVO | Aptevo Therapeutics | -$104.84K | — | -$70.00K | — | $9.01M | — | $1.46M | — | 11/10/2020 |
Aptevo Therapeutics (APVO) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-8.40 | $-83.20 | 89.9 % |
| Q1 | 2025-05-14 | $-87.80 | $-83.20 | -5.53 % |
| Q4 | 2025-02-15 | $-13.20 | $-84.20 | 84.3 % |
| Q3 | 2024-11-07 | $-355.20 | $-2.48K | 85.7 % |
Aptevo Therapeutics (APVO) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2022-08-11 | $0 | $3.42M | -100.0 % |
| Q1 | 2022-05-12 | $3.11M | $3.75M | -17.0 % |
| Q4 | 2022-03-24 | $3.67M | $3.40M | 7.79 % |
| Q3 | 2021-11-12 | $3.10M | $3.65M | -15.2 % |
PREGUNTAS FRECUENTES
¿Cuándo Aptevo Therapeutics (NASDAQ:APVO) publicará los resultados?
Está previsto que Aptevo Therapeutics (APVO) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 11, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Aptevo Therapeutics (NASDAQ:APVO)?
El BPA real fue de $-8.40, que superó la estimación de $-83.20.
¿Cuáles fueron los ingresos de Aptevo Therapeutics (NASDAQ:APVO)?
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.